🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Sotheby's to give Third Point three seats on board

Published 05/05/2014, 14:48
Updated 05/05/2014, 15:16
BID_old
-

(Reuters) - Sotheby's (N:BID) said it reached an agreement with Daniel Loeb's Third Point LLC, giving the hedge fund three seats on the auctioneer's board.

Under the deal, Sotheby's will also terminate its shareholder rights plan, or "poison pill," at its annual shareholder meeting on May 6.

The auctioneer said Third Point had withdrawn its lawsuit against the plan.

Billionaire activist Loeb had sued to remove Sotheby's poison pill, which prevents activist shareholders from owning 10 percent or more of the company.

Third Point, which currently owns just under 10 percent in Sotheby's, can raise its stake to up to 15 percent under the deal.

Apart from Loeb, Olivier Reza and Harry Wilson will be added to Sotheby's slate of directors up for election at the annual meeting, increasing the board to 15 members.

(Reporting by Soham Chatterjee in Bangalore; Editing by Kirti Pandey)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.